BRCA in breast cancer: ESMO Clinical Practice Guidelines.
نویسندگان
چکیده
BRCA in breast cancer: ESMO Clinical Practice Guidelines J. Balmaña, O. Diez, I. Rubio & M. Castiglione On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology; Oncogenetics Laboratory, University Hospital Vall d’Hebron; Vall d’Hebron Institute of Oncology (VHIO); Breast Cancer Surgical Unit, Breast Cancer Center, University Hospital Vall d’Hebron, Barcelona, Spain; RGT, University of Geneva, Geneva, Switzerland
منابع مشابه
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up F. Cardoso, L. Fallowfield, A. Costa, M. Castiglione & E. Senkus On behalf of the ESMO Guidelines Working Group* European School of Oncology, Milan, Italy; Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal; Brighton & Sussex Medical School, University of Sussex,...
متن کاملDifferential research impact in cancer practice guidelines’ evidence base: lessons from ESMO, NICE and SIGN
Background This is an appraisal of the impact of cited research evidence underpinning the development of cancer clinical practice guidelines (CPGs) by the professional bodies of the European Society for Medical Oncology (ESMO), the National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN). Methods A total of 101 CPGs were identified fr...
متن کاملBRCA in breast cancer: ESMO clinical recommendations.
Familial susceptibility to breast cancer accounts for 25% of all breast cancer cases. In familial breast cancer, mutations in the BRCA1, BRCA2, CHEK2, TP53 and PTEN genes account for 5–10% of breast and ovarian cancer cases overall. The prevalence of BRCA1 or BRCA2 mutations varies considerably between ethnic groups and geographical areas. Populationspecific mutations have been described in Ice...
متن کاملCase report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive?
The BRCA1/2 genes account for a significant portion of hereditary breast and ovarian cancers and they are especially prevalent in the Ashkenazi Jewish population. Women who have a mutation can prevent breast and ovarian cancer with surgical intervention. We describe an Ashkenazi Jewish patient who illustrates that current testing criteria are too restrictive, particularly for this population of...
متن کاملGastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A. Okines, M. Verheij, W. Allum, D. Cunningham & A. Cervantes On behalf of the ESMO Guidelines Working Group* GI Clinical Trials Unit, Royal Marsden Hospital, Sutton, UK; Department of Radiation Oncology and Division of Cellular Biochemistry, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of oncology : official journal of the European Society for Medical Oncology
دوره 22 Suppl 6 شماره
صفحات -
تاریخ انتشار 2010